Download PDF
Thromb Haemost 1975; 34(01): 306-308
DOI: 10.1055/s-0038-1651343
Letter to the Editor
Schattauer GmbH

A Method for Assaying von Willebrand Factor (Ristocetin Cofactor)

Donald E Macfarlane
1   Specialized Center for Thrombosis Research, Temple University Hospital, 3401 N. Broad Street, Philadelphia, Pa. 19140
,
Jeanne Stibbe
1   Specialized Center for Thrombosis Research, Temple University Hospital, 3401 N. Broad Street, Philadelphia, Pa. 19140
,
Edward P Kirby
1   Specialized Center for Thrombosis Research, Temple University Hospital, 3401 N. Broad Street, Philadelphia, Pa. 19140
,
Marjorie B Zucker
2   Department of Pathology, New York University, New York University Medical Center, New York, New York 10016
,
Robert A Grant
1   Specialized Center for Thrombosis Research, Temple University Hospital, 3401 N. Broad Street, Philadelphia, Pa. 19140
,
Jean McPherson
1   Specialized Center for Thrombosis Research, Temple University Hospital, 3401 N. Broad Street, Philadelphia, Pa. 19140
› Author Affiliations
Further Information

Publication History

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Allain J. P, Cooper H. A, Wagner R. H, and Brinkhous K. M. 1975; Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor. Journal of Laboratory and Clinical Medicine 85: 318.
    PubMedGoogle Scholar
  • 2 Grant P. A, McPherson J, and Zucker M. B. 1975; Inhibition and reversal by ADP of human platelet aggregation induced by ristocetin or porcine von Willebrand factor. Federation Proceedings 34: 222.
    PubMedGoogle Scholar
  • 3 Howard M. A, and Firkin B. G. 1971; Ristocetin - a new tool in the investigation of platelet aggregation. Thrombosis et Diathesis Haemorrhagica 26: 362.
    PubMedGoogle Scholar
  • 4 Kirby E. P, and Mills D. C. B. 1975 The interaction of bovine Factor VIII with human platelets. Journal of Clinical Investigation. In press.
    PubMedGoogle Scholar
  • 5 Olson J. D, Brockway W. J, Fass D. N, Magnuson M. A, and Bowie E. J. W. 1975; Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation. American Journal of Clinical Pathology 63: 210.
    CrossrefPubMedGoogle Scholar
  • 6 Meyer D, Jenkins C. S. P, Dreyfus M. D, Fressinaud E, and Larrieu M.-J. 1974; Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor VIII activity. British Journal of Haematology 28: 579.
    CrossrefPubMedGoogle Scholar
  • 7 Stibbe J, and Kirby E. P. 1975 a Inhibition of ristocetin-induced platelet aggregation by Haemaccel ® and fibrinogen. Abstract Vth International Congress of the International Society on Thrombosis and Haemostasis, Paris.
    PubMedGoogle Scholar
  • 8 Stibbe J, and Kirby E. P. 1975 b Influence of fibrinogen, albumin and Haemaccel on ristocetin-induced platelet aggregation; its relevance to the quantitative measurement of the ristocetin cofactor. In preparation.
    PubMedGoogle Scholar
  • 9 Weiss H. J, Hoyer L. W, Rickles F. R, Varma A, and Rogers J. 1973; Quantitative assay of plasma factor deficient in von Willebrand’s disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. Journal of Clinical Investigation 52: 2708.
    CrossrefPubMedGoogle Scholar
  • 10 Zimmerman T. S, Ratnoff O. D, and Powell A. E. 1971; Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand’s disease. Journal of Clinical Investigation 50: 244.
    CrossrefPubMedGoogle Scholar